Test Price
1,800 AED✅ Home Collection Available
Ganglioside GD1b Antibody IgG Test in UAE | 1800 AED | 2026 DHA Guidelines
تحليل الأجسام المضادة IgG لمُضاد الغانغليوزيد GD1b في الإمارات | 1800 درهم | مُعتمد من هيئة الصحة بدبي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139), fully compliant with UAE Federal Decree-Law No. 41 of 2024 (Art. 87) on medical data integrity.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy. Sample collected by DHA-licensed nurses between 8 AM – 11 PM, 7 days a week.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with our consultant neurologist, Dr. Prabhakar Reddy (DHA License 61713011).
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731. All major UAE insurance networks accepted. Pre‑approval arranged before collection.
ملخص تنفيذي: يضمن فحص الأجسام المضادة IgG لمُضاد الغانغليوزيد GD1b أعلى دقة تشخيصية وفق معايير هيئة الصحة بدبي ومختبرات مُعتمدة دولياً، مع خدمة سحب دم منزلي مُتميزة واستشارة هاتفية ما بعد النتيجة، بما يتوافق تماماً مع قانون حماية البيانات الشخصية الإماراتي.
Overview
The Ganglioside GD1b Antibody IgG test detects autoantibodies targeting the GD1b ganglioside, a glycolipid abundant in peripheral nerves, aiding the diagnosis of immune-mediated neuropathies such as Guillain-Barré syndrome (GBS) and Miller Fisher syndrome. يُستخدم الفحص لتأكيد الأمراض العصبية المناعية الذاتية ويُعد ضرورياً لوضع خطة علاج دقيقة.
| Feature | Our Test (DHA-MOHAP Compliant) | Closest Alternative (Regional Labs) |
|---|---|---|
| Methodology | Enzyme Immunoassay (EIA/ELISA) – gold standard for anti-ganglioside detection | Western Blot or indirect immunofluorescence (lower sensitivity, semi‑quantitative) |
| Diagnostic Specificity | ≥98% for GD1b-associated neuropathies (CLIA-certified validation) | ~90–93%, risk of false positives in cross‑reactive sera |
| Turnaround Time | 2–3 weeks from sample receipt (batch processed by 7th of each month) | Often 4–6 weeks, outsourced to overseas reference labs |
| Home Collection | Included, ISO cold‑chain transport | Limited or not available |
Physician Insight & Safety Protocol
“A positive anti-GD1b IgG result must always be interpreted alongside the clinical picture—weakness pattern, reflexes, and cerebrospinal fluid analysis. A low‑titer result in isolation rarely denotes active disease, while a high titer in a patient with acute flaccid paralysis strongly supports Guillain-Barré syndrome. I advise all patients not to self‑interpret but to discuss findings with their neurologist.”
— Dr. Prabhakar Reddy, Consultant Neurologist (DHA License: 61713011)
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. This test does not replace ongoing neurological therapy.
Exclusion Criteria & Safety Alerts
- Exclusion for Home Collection: Patient under 18 years (requires in‑clinic parental supervision per CDS Law 2026 – Minors); active febrile illness (>38.5°C) or current systemic infection.
- Drug Interference: High‑dose intravenous immunoglobulin (IVIg) or plasma exchange within the preceding 4 weeks may transiently lower autoantibody titers. Inform the phlebotomist of any immunosuppressive therapy.
- Emergency Red Flags: If you develop sudden worsening of limb weakness, difficulty breathing, swallowing problems, or double vision, do not wait for test results—seek immediate emergency medical attention (call 998 for UAE ambulance).
- Mandatory Consent: A duly filled Test Send Out Consent Form (Form 35) is mandatory. Overnight fasting (10-12 hours) is preferred. Sample: 2 mL serum (1 mL minimum) from 1 SST, ship refrigerated or frozen.
Patient FAQ & Clinical Guidance
Q1: What is the clinical significance of anti-GD1b IgG antibodies?
Anti-GD1b IgG antibodies are diagnostic biomarkers strongly associated with acute motor axonal neuropathy and sensory ataxic variants of Guillain-Barré syndrome, helping neurologists differentiate autoimmune neuropathies from other neurological disorders. الأجسام المضادة لـ GD1b IgG ترتبط باعتلال الأعصاب المناعي الذاتي مثل متلازمة غيلان باريه وتساعد في التمييز بين أنواع الاعتلال العصبي المختلفة.
Q2: How should I prepare for the GD1b antibody blood draw?
You must observe an overnight fast (water permitted) and complete the mandatory Test Send Out Consent Form (Form 35) signed by your ordering physician before our DHA-licensed phlebotomist arrives. يجب الصيام طوال الليل (يُسمح بالماء) وتوقيع نموذج الموافقة الإلزامي (نموذج 35) من الطبيب المُعالج قبل سحب العينة.
Q3: Why does the report take 2–3 weeks, and how are results delivered?
The GD1b IgG ELISA is a batch‑processed specialized assay that requires a minimum sample volume by the 7th of each month; once run, results undergo a rigorous two‑step validation and are released to you securely via the patient portal with the option of a tele‑consult. يتم إجراء الفحص على دفعات شهرية لضمان الدقة، وبعد اكتمال التحقق المزدوج تُصدر النتائج خلال 2–3 أسابيع وتُرسل عبر البوابة الإلكترونية الآمنة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians